Robust immunoreactivity of teenager sera against peptide 19 from Porphyromonas gingivalis HSP60.
10.5051/jpis.2017.47.3.174
- Author:
Eun Young KWON
1
;
Gil Sun CHA
;
Ji Young JOO
;
Ju Youn LEE
;
Jeomil CHOI
Author Information
1. Department of Periodontology, Pusan National University School of Dentistry, Yangsan, Korea. rapa@pusan.ac.kr
- Publication Type:Original Article
- Keywords:
Autoimmunity;
Heat-shock proteins;
Porphyromonas gingivalis
- MeSH:
Adolescent*;
Autoimmune Diseases;
Autoimmunity;
Chlamydophila pneumoniae;
Diabetes Mellitus, Type 1;
Epitopes;
Healthy Volunteers;
Heat-Shock Proteins;
Humans;
Immunodominant Epitopes;
Mycobacterium tuberculosis;
Peptides;
Periodontitis;
Porphyromonas gingivalis*;
Porphyromonas*
- From:Journal of Periodontal & Implant Science
2017;47(3):174-181
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Epitope spreading is a phenomenon in which distinct subdominant epitopes become major targets of the immune response. Heat shock protein (HSP) 60 from Porphyromonas gingivalis (PgHSP60) and peptide 19 from PgHSP60 (Pep19) are immunodominant epitopes in autoimmune disease patients, including those with periodontitis. It remains unclear whether Pep19 is a dominant epitope in subjects without periodontitis or autoimmune disease. The purpose of this study was to determine the epitope spreading pattern and verify Pep19 as an immunodominant epitope in healthy teenagers using dot immunoblot analysis. The patterns of epitope spreading in age-matched patients with type 1 diabetes mellitus (type 1 DM) and healthy 20- to 29-year old subjects were compared with those of healthy teenagers. METHODS: Peptide from PgHSP60, Mycobacterium tuberculosis HSP60 (MtHSP60), and Chlamydia pneumoniae HSP60 (CpHSP60) was synthesized for comparative recognition by sera from healthy subjects and patients with autoimmune disease (type 1 DM). Dot immunoblot analysis against a panel of peptides of PgHSP60 and human HSP60 (HuHSP60) was performed to identify epitope spreading, and a densitometric image analysis was conducted. RESULTS: Of the peptide from PgHSP60, MtHSP60, and CpHSP60, PgHSP60 was the predominant epitope and was most consistently recognized by the serum samples of healthy teenagers. Most sera from healthy subjects and patients with type 1 DM reacted more strongly with PgHSP60 and Pep19 than the other peptides. The relative intensity of antibody reactivity to Pep19 was higher in the type 1 DM group than in the healthy groups. CONCLUSIONS: Pep19 is an immunodominant epitope, not only in autoimmune disease patients, but also in healthy young subjects, as evidenced by their robust immunoreactivity. This result suggests that the Pep19-specific immune response may be an initiator that triggers autoimmune diseases.
